These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35188495)

  • 1. IMPAIRMENTS IN CONE PIGMENT REGENERATION AND ABSOLUTE THRESHOLD IN MACULAR TELANGIECTASIA TYPE 2.
    Simunovic MP; Hess K; Gillies MC
    Retina; 2022 Mar; 42(3):569-575. PubMed ID: 35188495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dark-Adapted Two-Color Fundus-Controlled Perimetry in Macular Telangiectasia Type 2.
    Heeren TFC; Tzaridis S; Bonelli R; Pfau M; Fruttiger M; Okada M; Egan C; Charbel Issa P; Holz FG
    Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1760-1767. PubMed ID: 31022297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DARK ADAPTATION IN MACULAR TELANGIECTASIA TYPE 2.
    Tzaridis S; Hess K; Heeren TFC; Nadal J; Mai C; Herrmann P; Charbel Issa P; Holz FG
    Retina; 2020 Oct; 40(10):2018-2025. PubMed ID: 31800456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CONE DENSITY LOSS ON ADAPTIVE OPTICS IN EARLY MACULAR TELANGIECTASIA TYPE 2.
    Jacob J; Krivosic V; Paques M; Tadayoni R; Gaudric A
    Retina; 2016 Mar; 36(3):545-51. PubMed ID: 26418443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topography of cone dark adaptation deficits in age-related maculopathy.
    Gaffney AJ; Binns AM; Margrain TH
    Optom Vis Sci; 2011 Sep; 88(9):1080-7. PubMed ID: 21705940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abdominal obesity linked to a longer cone-mediated dark-adaptation recovery time in healthy eyes.
    Puell MC; Fernandez-Balbuena AÁ
    Exp Eye Res; 2019 Apr; 181():163-170. PubMed ID: 30738070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE NATURAL HISTORY OF FULL-FIELD STIMULUS THRESHOLD DECLINE IN CHOROIDEREMIA.
    Dimopoulos IS; Freund PR; Knowles JA; MacDonald IM
    Retina; 2018 Sep; 38(9):1731-1742. PubMed ID: 28800019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMPAIRMENTS OF L-CONE/M-CONE AND S-CONE-MEDIATED COLOR DISCRIMINATION IN MACULAR TELANGIECTASIA TYPE II.
    Simunovic MP; Gillies MC
    Retina; 2022 Mar; 42(3):576-580. PubMed ID: 35188496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive optics microperimetry and OCT images show preserved function and recovery of cone visibility in macular telangiectasia type 2 retinal lesions.
    Wang Q; Tuten WS; Lujan BJ; Holland J; Bernstein PS; Schwartz SD; Duncan JL; Roorda A
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):778-86. PubMed ID: 25587056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cone pathologic changes in idiopathic macular telangiectasia types 1 and 2 using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Takayama K; Ueda-Arakawa N; Tsujikawa A; Yamashiro K; Oishi A; Hanebuchi M; Yoshimura N
    Am J Ophthalmol; 2013 Jun; 155(6):1045-1057.e4. PubMed ID: 23465268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8.
    Heeren TFC; Chew EY; Clemons T; Fruttiger M; Balaskas K; Schwartz R; Egan CA; Charbel Issa P;
    Ophthalmology; 2020 Nov; 127(11):1539-1548. PubMed ID: 32586743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cone- and rod-mediated dark adaptation impairment in age-related maculopathy.
    Owsley C; McGwin G; Jackson GR; Kallies K; Clark M
    Ophthalmology; 2007 Sep; 114(9):1728-35. PubMed ID: 17822978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging and cone dark adaptation.
    Gaffney AJ; Binns AM; Margrain TH
    Optom Vis Sci; 2012 Aug; 89(8):1219-24. PubMed ID: 22773176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Threshold versus intensity functions in two-colour automated perimetry.
    Simunovic MP; Hess K; Avery N; Mammo Z
    Ophthalmic Physiol Opt; 2021 Jan; 41(1):157-164. PubMed ID: 33063858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring rod and cone dynamics in age-related maculopathy.
    Dimitrov PN; Guymer RH; Zele AJ; Anderson AJ; Vingrys AJ
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):55-65. PubMed ID: 18172075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
    Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FLUORESCENCE LIFETIME PATTERNS IN MACULAR TELANGIECTASIA TYPE 2.
    Solberg Y; Dysli C; Wolf S; Zinkernagel MS
    Retina; 2020 Jan; 40(1):99-108. PubMed ID: 30664123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast sensitivity and visual acuity under low light conditions in macular telangiectasia type 2.
    Müller S; Heeren TFC; Bonelli R; Fruttiger M; Charbel Issa P; Egan CA; Holz FG
    Br J Ophthalmol; 2019 Mar; 103(3):398-403. PubMed ID: 29858186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relating Retinal Morphology and Function in Aging and Early to Intermediate Age-related Macular Degeneration Subjects.
    Sevilla MB; McGwin G; Lad EM; Clark M; Yuan EL; Farsiu S; Curcio CA; Owsley C; Toth CA
    Am J Ophthalmol; 2016 May; 165():65-77. PubMed ID: 26940163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.